Galenica AG: Double-digit growth in profits for the 18th consecutive year
March 12, 2014 | by Galenica AG
Reading time: 2 minutes
March 12, 2014, Galenica increased consolidated net sales by 2.0% to CHF 3,359.4 million in 2013. On a comparable basis, profit before deduction of minority interests increased by 7.8% to CHF 296.2 million and after deduction of minority interests by 1.6% to CHF 257.6 million. Taking into account positive one-time effects due to IAS 19 and the settlement of an international tax case, net profit saw a double-digit growth for the 18th consecutive year, by 21.1% to CHF 334.8 million before and by 16.1% to CHF 296.2 million after deduction of minority interests. At the Annual General Meeting 2014, the Board of Directors will recommend a dividend increase of 27.3% to CHF 14.00 per registered share.
Among the highlights of 2013 were US Food and Drug Administration (FDA) approvals for Injectafer® for the treatment of iron deficiency anaemia and for Velphoro® to control serum phosphorus levels in patients with chronic kidney disease on dialysis. Further milestones were the acquisition of Medifilm, the leading Swiss company in the field of blister packaging for medicines, as well as the acquisition of a minority stake in the pharmacy Bahnhof Apotheke Zurich.
In 2014, Vifor Pharma will continue to expand Ferinject® in international markets, will support its partner Luitpold Pharmaceuticals, Inc. with the launch of Injectafer® in the US and will prepare further registrations and the commercialisation of Velphoro®. Logistics, Retail and HealthCare Information will continue to expand their business activities and to implement the projects already launched in order to optimise processes and improve profitability.
Galenica management has set itself the target of achieving at least the same level of profit in 2014 as in the previous year on a comparable basis, both before and after deduction of minority interests.
Media contact:
Christina Hertig Tel. 058 852 85 17 E-Mail: media@galenica.com
Editor's note: Image rights belong to the respective publisher.
Conclusion of this article: « Galenica AG: Double-digit growth in profits for the 18th consecutive year »
Source: Galenica AG, Press release